Image

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Testing a new Ofatumumab dosing schedule for safety and effects.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)
Study Overview: This research is designed to test a new dosage of a medication called ofatumumab for people with relapsing multiple sclerosis (MS). Multiple sclerosis is a condition where the immune system attacks the protective covering of nerves. The study will check how the body processes the medication (pharmacokinetics), how it works in the body (pharmacodynamics), and its safety. Key Points:
  • The study is open to adults aged 18-60 with certain forms of relapsing MS.
  • Participants must not have other immune-related diseases or infections and should not be pregnant or nursing.
  • This is a Phase 3 study, meaning the medication has been tested before and researchers are studying its effectiveness and safety further.
Eligible participants must sign a consent form and should not have certain diseases like active infections, hepatitis, or a history of certain cancers. Women who are pregnant or breastfeeding cannot join. The study is conducted at multiple locations and requires participants to be committed and cooperative throughout.
Print
Study details
    Relapsing Multiple Sclerosis (RMS)

NCT06869785

Novartis Pharmaceuticals

7 June 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.